Expertise in
10
conditions

Jung Y. Hong

Seoul, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
Seoul, KR 

Overview

Jung Hong practices practicing medicine in Seoul, Republic of Korea.

Hong is highly rated in 10 conditions, according to our data. Their clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 187 peer reviewed articles and participating in 1 clinical trial.

Locations

Seoul, Republic of Korea
Other Locations
Ansan, Republic of Korea
Gangneung, Republic of Korea
Gyeonggi-do, Republic of Korea
Republic of Korea
Wondu, Republic of Korea
Seoul St. Mary's Hospital, #505 Banpo Dong, Seocho, 137701, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2

187 Total Publications

Utility of the neutrophil-to-lymphocyte ratio extends to patients from East Asia.
Utility of the neutrophil-to-lymphocyte ratio extends to patients from East Asia.
Journal: The Journal of clinical investigation
Published: March 16, 2026

Frequently Asked Questions about Jung Y. Hong

Is Jung Y. Hong a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Jung Y. Hong is classified as an Advanced expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jung Y. Hong participate in research or clinical trials?

Yes. Jung Y. Hong has published 187 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Jung Y. Hong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hong's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 47 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile